Estee Lauder (EL)

• Market cap: $28B
• 1 day: -0.27%
• 5 days: 5.90%
• 1 month: -0.41%
• 3 months: -14.38%
• 6 months: -22.67%
• Year to date: 5.24%
• 1 year: -38.34%
• 5 years: -64.59%
• 10 years: 4.47%
• Sector: Materials
• Industry: Perfumes, Cosmetics & Other Toilet Preparations

About: Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Employees: 62,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

5% less repeat investments, than reductions

Existing positions increased: 325 | Existing positions reduced: 342

4.74% less ownership

Funds ownership: 90.83% [Q2] → 86.09% (-4.74%) [Q3]

8% less funds holding

Funds holding: 970 [Q2] → 892 (-78) [Q3]

12% less capital invested

Capital invested by funds: $22.5B [Q2] → $19.9B (-$2.61B) [Q3]

15% less call options, than puts

Call options by funds: $1.03B | Put options by funds: $1.22B

37% less first-time investments, than exits

New positions opened: 107 | Existing positions closed: 171

40% less funds holding in top 10

Funds holding in top 10: 10 [Q2] → 6 (-4) [Q3]

Research analyst outlook

18 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $70 10% downside
• Avg. target: $81 4% upside
• High target: $125 61% upside

18 analyst ratings

• positive: 3 17%
• neutral: 15 83%
• negative: 0 0%

Barclays Lauren Lieberman 43% 1-year accuracy 39 / 90 met price target	9% downside $71	Equal-Weight Maintained	17 Jan 2025
UBS Peter Grom 41% 1-year accuracy 9 / 22 met price target	3% upside $80	Neutral Maintained	16 Jan 2025
JP Morgan Andrea Teixeira 39% 1-year accuracy 21 / 54 met price target	1% upside $79	Neutral Maintained	16 Jan 2025
Wells Fargo Christopher Carey 0% 1-year accuracy 0 / 3 met price target	5% downside $74	Equal-Weight Maintained	7 Jan 2025
Piper Sandler Korinne Wolfmeyer 36% 1-year accuracy 16 / 45 met price target	17% upside $91	Overweight Maintained	6 Jan 2025